Key result
This review summarizes contemporary data from the UK TAVI and US TVT registries on patient profiles and outcomes for transcatheter aortic valve replacement in severe aortic stenosis.
This review summarizes contemporary data from the UK TAVI and US TVT registries to aid in patient selection and guide discussions for TAVR in severe aortic stenosis.
Longer-term TAVR outcomes in severe AS remain incompletely defined; leaves open need for extended prospective data.
The introduction of transcatheter aortic valve replacement (TAVR in US - TAVI in Europe) has resulted in a paradigm shift in the treatment of patients with severe aortic stenosis. Although three randomized trials and multiple single-center and multicenter registry studies have been published, the profile and longer-term outcome of patients undergoing transcatheter aortic valve replacement (TAVR) in patients with severe aortic stenosis have been limited. The recently published reports from the United Kingdom (UK)(1) and United States (US)(2) TAVR registries add tremendously to the currently available literature. These studies provide an excellent model to clinicians that would aid in the proper patient selection and help in guiding discussions with patients who are undergoing TAVR. The present review discusses the recently published UK and US TAVR registry data.
No takes yet. Share an insight, caveat, or question.
Suradi et al. (2015) conducted a review in severe aortic stenosis. Transcatheter aortic valve replacement (TAVR) was evaluated. This review summarizes contemporary data from the UK TAVI and US TVT registries on patient profiles and outcomes for transcatheter aortic valve replacement in severe aortic stenosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: